AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.

These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes. 

  • VASCULAR INTERVENTIONS & THERAPIES
  • VASCULAR ACCESS
  • ONCOLOGY

Changing Lives

Each day, AngioDynamics and its employees earn the trust of patients and the medical community by being a committed partner that continuously focuses on delivering safer, clinically-relevant and economically-favorable solutions that help improve patient outcomes.

View Patient Stories
Patients Are The Focus
Warren's Story

Being innovative is one thing, being part of a patient's...continuum of care, that's something that makes me get up every day and it's a powerful feeling.


Our Culture is Our Success

Become a proud member of our team

It takes a team of talented people to become one of the world’s leading providers of innovative medical devices. 

The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.

If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.

ALERT: AngioDynamics has received reports of an active phishing scam that involves the perpetrators falsely posing as an employee of the Company and seeking the private information of individuals.

If you believe you have received this scam message, please do the following:

• Do not respond to the message.

• Do not click on any attachments or links.

• Do not call any number listed.

• Do not provide any private information such as username and password.

• Delete the message.

Please note: AngioDynamics’ Human Resources department will NEVER ask you to purchase anything when receiving/accepting an offer of employment; or ask you to click any links to validate or verify private information prior to receiving an authorized offer of employment at the conclusion of an interview process with authorized employees.

Suspicious attempts to obtain private information should be reported to the proper authorities. 

View Open Positions
29 Sep, 2020

AngioDynamics Reports Fiscal 2021 First Quarter Financial Results
21 Sep, 2020

AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States

World Congress on Vascular Access (WoCoVA)

Date: 07 Apr, 2021
Time:
Location: Athens, Greece

17 Sep, 2020

AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020
17 Aug, 2020

AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System
More News & Events

New Developments

AngioDynamics Reports Fiscal 2021 First Quarter Financial Results

Fiscal 2021 First Quarter HighlightsNet sales of $70.2 million increased 6.3% compared to the prior-year quarter, inclusive of the previously disclosed $5.2 million order from the ...

Read More

Our Reach is Global

AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.

Offices in:

USA

  • Latham, NY (HQ)
  • Glens Falls, NY (Manufacturing)
  • Queensbury, NY (Manufacturing)
  • Marlborough, MA (R&D)

International

  • Amsterdam, NL
    (International HQ)
  • São Paulo, BR
    (Brazil Office)
  • Oakville, CA
    (Canada Office)
  • Hong Kong, HK
    (Asia Pacific Regional Office)
  • Rehovot, IL
    (Israel Office)